Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

12.5%

7 terminated/withdrawn out of 56 trials

Success Rate

84.4%

-2.1% vs industry average

Late-Stage Pipeline

23%

13 trials in Phase 3/4

Results Transparency

3%

1 of 38 completed trials have results

Key Signals

6 recruiting1 with results4 withdrawn

Enrollment Performance

Analytics

Phase 4
7(25.0%)
N/A
6(21.4%)
Phase 3
6(21.4%)
Phase 1
5(17.9%)
Phase 2
4(14.3%)
28Total
Phase 4(7)
N/A(6)
Phase 3(6)
Phase 1(5)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (56)

Showing 20 of 56 trials
NCT04529434Not ApplicableCompleted

Star Homes Project 2

Role: collaborator

NCT07468513Phase 4Recruiting

Primaquine for Vivax Malaria in G6PD Intermediate and Deficient Cases.

Role: collaborator

NCT07439692Recruiting

ICU-related Out of Pocket Expenses (ICOPE)

Role: collaborator

NCT07232901Not ApplicableCompleted

Implementing Family Participation Training in Tertiary Hospital Care in Bangladesh

Role: collaborator

NCT03379402Completed

Sepsis-3 Study in Northeast Thailand

Role: collaborator

NCT04080895Phase 1Terminated

Pharmacokinetic Study of Artemether-lumefantrine and Amodiaquine in Healthy Subjects

Role: collaborator

NCT04629053Recruiting

Causes and Outcomes of Febrile Illness in Health Facilities in Rural South and Southeast Asia

Role: collaborator

NCT06575647Phase 4Completed

Vivax Elimination With Tafenoquine (VET) Study

Role: collaborator

NCT05968066Completed

Practice of Fluid Therapy in Critically Ill Invasively Ventilated Patients

Role: collaborator

NCT03923725Phase 3Completed

A Trial to Compare the Efficacy, Safety and Tolerability of Combinations of 3 Anti-malarial Drugs Against Combina-tions of 2 Anti-malarial Drugs.

Role: collaborator

NCT06191458Phase 4Completed

Postpartum Primaquine in Breast Milk

Role: collaborator

NCT06089668Completed

An Observational Study to Evaluate Clinical Characteristics of Adult Patients With Suspected or Confirmed Melioidosis

Role: collaborator

NCT05788094Phase 4Recruiting

ACT vs CQ With Tafenoquine for P. Vivax Mono-infection

Role: collaborator

NCT05045547Completed

Village Malaria Worker Expansion

Role: collaborator

NCT05972772Phase 2Recruiting

Rickettsia Clearance Study

Role: collaborator

NCT06632275Completed

Family Participation in Bangladesh Hospital Care

Role: collaborator

NCT04411836Phase 3Completed

Effectiveness of Novel Approaches to Radical Cure With Tafenoquine and Primaquine

Role: collaborator

NCT04478578Recruiting

Incidences, Causes, and Outcomes of Febrile Illness in Rural South and Southeast Asia

Role: collaborator

NCT05938608Phase 1Withdrawn

A Study to Assess the Availability of Oral Primaquine and Its Inert Metabolite, Carboxyprimaquine, in the Body

Role: collaborator

NCT04984759Phase 4Withdrawn

Tafenoquine and Primaquine in Colostrum and Breast Milk

Role: collaborator